iBio Inc
Research iBio Inc (IBIO) on Bullrun: market cap USD 85.94M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerIBIO
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 85.94M
- Financial periodFY2025
- RevenueUSD 400.00K
- Revenue growth77.8%
- Net income-USD 18.38M
- Free cash flow-USD 15.32M
Valuation Snapshot
latest market cap is USD 85.94M.
About iBio Inc
iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology;
Frequently asked questions
What is iBio Inc's market cap?
iBio Inc's market capitalization is USD 85.94M.
What does iBio Inc do?
iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel;